Analysts: Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

1,221.55INR
5:26am EST
Change (% chg)

Rs43.40 (+3.68%)
Prev Close
Rs1,178.15
Open
Rs1,184.00
Day's High
Rs1,228.00
Day's Low
Rs1,175.10
Volume
1,405,898
Avg. Vol
1,058,705
52-wk High
Rs1,228.00
52-wk Low
Rs423.10

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 14.29 March 29 Jan 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 7 9 9 7
(2) OUTPERFORM 9 8 8 7
(3) HOLD 5 6 6 5
(4) UNDERPERFORM 1 1 1 2
(5) SELL 0 0 0 1
No Opinion 0 0 0 0
Mean Rating 2.00 1.96 1.96 2.23

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 2 21,615.50 31,381.00 11,850.00 22,034.00
Quarter Ending Jun-15 1 32,693.00 32,693.00 32,693.00 --
Year Ending Mar-15 21 120,627.00 125,624.00 115,856.00 90,399.60
Year Ending Mar-16 21 137,731.00 151,780.00 129,259.00 106,585.00
Earnings (per share)
Quarter Ending Mar-15 1 14.29 14.29 14.29 9.47
Quarter Ending Jun-15 1 13.51 13.51 13.51 --
Year Ending Mar-15 22 56.18 64.40 48.00 34.37
Year Ending Mar-16 22 67.09 81.10 53.50 43.51
LT Growth Rate (%) 2 16.60 21.20 12.00 39.30

Historical Surprises

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 28,968.30 28,621.90 346.37 1.20
Quarter Ending Jun-14 28,841.40 28,946.10 104.73 0.36
Quarter Ending Mar-14 21,786.40 23,058.80 1,272.39 5.84
Quarter Ending Dec-13 19,607.70 21,355.20 1,747.50 8.91
Quarter Ending Sep-13 18,541.50 18,974.80 433.30 2.34
Earnings (per share)
Quarter Ending Sep-14 12.40 12.76 0.36 2.88
Quarter Ending Jun-14 15.31 14.24 1.07 6.97
Quarter Ending Mar-14 14.90 17.21 2.31 15.51
Quarter Ending Dec-13 7.90 14.32 6.42 81.21
Quarter Ending Sep-13 6.42 8.06 1.64 25.50

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-15 21,615.50 21,615.50 21,615.50 21,615.50 22,034.00
Quarter Ending Jun-15 32,693.00 32,693.00 32,693.00 32,693.00 --
Year Ending Mar-15 120,627.00 120,627.00 120,498.00 118,738.00 90,399.60
Year Ending Mar-16 137,731.00 137,731.00 137,496.00 135,343.00 106,585.00
Earnings (per share)
Quarter Ending Mar-15 14.29 14.29 14.29 14.29 9.47
Quarter Ending Jun-15 13.51 13.51 13.51 13.51 --
Year Ending Mar-15 56.18 56.22 56.22 54.81 34.37
Year Ending Mar-16 67.09 67.08 67.12 65.38 43.51

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-15 0 0 0 0
Quarter Ending Jun-15 0 0 0 0
Year Ending Mar-15 0 0 1 0
Year Ending Mar-16 0 0 1 0
Earnings
Quarter Ending Mar-15 0 0 0 0
Quarter Ending Jun-15 0 0 0 0
Year Ending Mar-15 0 1 0 2
Year Ending Mar-16 1 0 1 1

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Spark Capital Advisors(India) Private Limited
$35.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks